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New Aspects of Nitrite Homeostasis  
in Human Skin
Christian Opländer1 and Christoph V. Suschek1
Enzymatic as well as nonenzymatic mechanisms generate nitric oxide (NO) 
from nitrite in the blood, stomach, saliva, and urine, as well as in the skin. In 
human skin, the inorganic anions nitrate and nitrite are not inert end products 
of endogenous nitric oxide metabolism, as long believed, but can be recycled 
by environmental stimuli such as UVA radiation to form NO; thus, they repre-
sent an important alternative nonenzymatic physiological source of NO.
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Several lines of evidence indicate that 
nitric oxide (NO) is involved in various 
physiological as well as pathophysiologi-
cal reactions in the skin, including hair 
growth, proliferation and differentiation 
of epidermal cells, control of wound 
healing, microbicidal activity, antigen 
presentation, allergic skin manifestations, 
regulation of innate immune reactions, 
and inflammatory responses. In addi-
tion, UV-induced processes such as ery-
thema and edema formation, as well as 
melanogenesis, are affected by NO (for 
review, see Weller, 2003). Furthermore, 
NO is an effective inhibitor of lipid per-
oxidation, and the coordinated action of 
NO on the expression of cell-protecting 
genes, as well as preservation of mem-
brane function, may play an important 
role in protection against either UVA- or 
reactive oxygen species-induced apop-
totic or necrotic cell death (for review, 
see Suschek et al., 2006). NO is endog-
enously synthesized by NO synthases 
(NOSs), an enzyme family consisting of 
three members, constitutively expressed 
neuronal NOS, endothelial NOS, and a 
cytokine-inducible isoform.
In human skin, NOS-dependent pro-
duction of NO potentially occurs in all 
cell types by at least one of the three NO 
synthases. Because NO is a radical, its 
sphere of influence extends only to sev-
eral cell diameters. Therefore, NO truly 
is a local mediator that does not need 
complex metabolism for clearance. It 
is simply diluted and then oxidized to 
nitrite and nitrate over time. However, 
storage pools for NO do exist, with 
S-nitrosothiols, N-nitroso compounds, 
nitrite, and nitrate being the most impor-
tant. The inorganic anion nitrite (NO2–) 
was previously thought to be an inert 
end product of endogenous NO metab-
olism. However, recent studies demon-
strated that this supposedly inert anion 
can be recycled in vivo to form NO, 
representing an important alternative 
source of NO to the classic l-arginine–
NO synthase pathway (Suschek et al., 
2006).
In blood, nitrite contributes to blood 
flow regulation by reaction with deoxy-
genated hemoglobin and tissue heme 
proteins to form NO, and plasma nitrite 
levels decrease progressively with 
increasing cardiovascular risk, such as 
hyperlipidemia, arterial hypertension, 
and smoking. Nonenzymatic NO gen-
eration from nitrite has been reported 
at several other sites in humans. In the 
stomach, NO is formed from nitrite at 
acidic pH, which requires continuous 
delivery of saliva-containing nitrite. 
NO increases mucous barrier thickness 
and gastric blood flow and shortens the 
time required to kill ingested pathogens 
within the normal residence time of 
food in the stomach. A similar mecha-
nism of NO generation from acidified 
salivary nitrite has been detected in the 
oral cavity, where NO is suggested to 
play a role in host defense. Acidification 
of urine, such as occurs following intake 
of vitamin C, results in NO generation 
from urinary nitrite and acts as a bacte-
riostatic, with respective consequences 
in urinary bladder pathophysiology (for 
review, see Lundberg et al., 2008).
Application of near-physiological 
nitrite concentrations results in 
NO-dependent cytoprotection from 
cardiac and liver ischemia–reperfusion 
injury in mice. In addition, a 2-week 
infusion of nitrite prevented delayed 
cerebral vasospasm in a primate model 
of subarachnoid hemorrhage, suggesting 
that nitrite serves as a backup source of 
NO, buffering tissue temporarily against 
severe hypoxia and providing protection 
via compensatory vasodilation.
In the context of skin physiology, 
nitrite action is of particular importance. 
During challenge of normal human skin 
with environmentally relevant UVA 
doses, nitrite and nitroso compounds 
decompose and enzyme-independently 
form NO at manifold higher concentra-
tions than are found with maximal induc-
ible NOS activity in cytokine-activated 
human keratinocyte cultures in vitro. 
These findings indicate that human skin 
uses naturally occurring NO donor mol-
ecules, which during sunlight exposure 
will lead to non-enzyme-derived high-
output NO formation. Furthermore, 
in the acidic milieu of human skin, 
acid-induced decomposition of nitrite 
represents an additional source of non-
enzymatic cutaneous NO production 
(for review, see Suschek et al., 2006). 
Pharmacological intervention with 
nitrite-derived high-output NO after 
acidification appeared to be a promis-
ing treatment for conditions such as 
infectious diseases of the skin or the 
vasoconstriction of Raynaud’s disease, 
where a significant vasodilatation has 
been demonstrated using this NO donor 
system (Tucker et al., 1999).
In the past 20 years, an ongoing dis-
cussion in the NO research field has 
included attempts to typify the physi-
ological or pathophysiological character 
of NO: is it good, bad, or ugly? The cellu-
lar response to increases in intracellular 
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NO concentration seems to depend 
largely on the redox potential of the cell, 
which is itself influenced by the resting 
levels of NO. In human skin cells and 
tissues, even supraphysiological high 
NO concentrations were shown to pro-
tect cells from oxidative stress and UVA-
induced apoptosis. In other cell systems, 
NO promoted apoptosis even at “physi-
ological” concentrations, earning it the 
epithet “the Janus-faced molecule.”
But what is the character of nitrite in 
human skin as a potential NO donor 
during UVA exposure? In rat endothe-
lial cells, nitrite-derived NO formation 
represented an effective protective prin-
ciple against UVA-induced cell inju-
ries, even at concentrations of 10 mM 
nitrite (Suschek et al., 2003). Further, 
physiological intracellular nitrite con-
centrations significantly reduce the 
susceptibility of human skin fibroblasts 
to UVA-induced cell death. Thus, fibro-
blasts depleted of intracellular nitrite die 
at significantly lower UVA doses than 
fibroblast cultures supplemented with 
skin-physiological nitrite concentrations 
of 10 µM (Opländer et al., 2008). In this 
setting, skin-derived nitrite seems to be 
the “good guy,” and it seems feasible that 
in special circumstances nitrite and other 
sources of enzyme-independent NO for-
mation may play a pivotal role in human 
skin physiology, as is postulated for NO 
itself. On the other hand, with human 
skin fibroblasts, experiments identical 
to those performed with rat endothelial 
cells mentioned above reveal that nitrite 
at supraphysiological concentrations of 
100 µM readily augments UVA-induced 
cell death because of the simultaneous 
generation of highly toxic •NO2 radi-
cals, a side product of UVA-induced 
nitrite decomposition (Opländer et al., 
2007). Then, is nitrite the “bad guy”? 
Although cutaneous NO formation via 
photodecomposition of nitrite repre-
sents an effective antioxidative and pro-
tecting role for NO, the simultaneous 
production of •NO2 represents a strong 
toxic insult. Thus, depending on the indi-
vidual antioxidative equipment of a cell 
type, during UVA exposure nitrite might 
protect against UVA-induced oxidative 
stress or enhance the injurious effects of 
UVA. Nitrite, as NO, has a redox-depen-
dent Janus-faced character.
Because of nitrite’s Janus characteris-
tics, it is important to know more about 
the physiological concentrations of 
cutaneous NO-related products, as well 
as the possible regulatory mechanisms 
of cutaneous nitrite homeostasis. It has 
been postulated that the amount of skin-
derived NO derivates solely reflects the 
NO amount produced by skin cells. It 
was assumed that some of the NO mole-
cules formed in skin remain at or close to 
the point of generation in the chemical 
form of S- or N-nitroso compounds or as 
the oxidation products nitrite or nitrate. 
Concentrations of up to 10 µM nitrite 
were detected in human skin specimens, 
representing a more than 25 times higher 
concentration of these compounds than 
that reported in the plasma of healthy 
volunteers (Paunel et al., 2005). In this 
issue, Mowbray et al. present in vivo data 
that confirm and quantify the presence of 
NO-related products in human epider-
mis, superficial vascular dermis, and skin 
surface sweat. These species have been 
shown to exhibit an ability to release NO 
during UVA exposure, findings that are 
of great significance in the context of the 
skin as the largest ‘‘organ’’ of the human 
body (10–20 dm3), which thus offers a 
considerable storehouse. A further sur-
prising and innovative finding is the 
discovery of a relationship between the 
concentration of NO-related products in 
plasma and those in the superficial vas-
cular dermis and sweat.
Mowbray et al. (2009) further describe 
a strong interindividual variation in the 
concentration of NO-related products 
in saliva, plasma, sweat, epidermis, 
and superficial vascular dermis that 
was similar in each of the biological 
samples. Gladwin et al. (for review, see 
Gladwin et al., 2005) suggested that the 
majority of nitrite in tissues originates 
from the exogenous intake of nitrite 
and nitrate and not from endogenous 
sources, thus resulting in great variation 
in tissue nitrite levels with nitrate and 
nitrite intake. In contrast, plasma levels 
of nitrite vary only slightly, suggesting 
the existence of regulatory pathways in 
blood (Bryan et al., 2005).
The main sources of nitrate and 
nitrite in our diet are green vegetables 
(such as lettuce and spinach), root veg-
etables, cured meat, and water. In vari-
ous European countries and the United 
States, estimated dietary intakes of nitrate 
and nitrite range from 31 to 185 mg/day 
and from 0.7 to 8.7 mg/day, respective-
ly. Upon rigorous exclusion of dietary 
nitrate, urinary excretion in human vol-
unteers is about 1 mmol nitrate per day 
(i.e., an amount similar to that provided 
by food). This suggests that the amount 
of nitrate synthesized endogenously 
by NO synthases is comparable to the 
amount of nitrate ingested.
Because NO-related products in 
plasma can be influenced by dietary 
intake of nitrate or nitrite, Mowbray 
et al. (2009) postulate that dietary 
NO derivates may offer a source for 
manipulation of cutaneous NO-related 
products and that an individual’s 
dietary consumption of green leafy 
vegetables may, in part, influence his 
cutaneous response to UV radiation. 
It is well known that vegetarians are 
at a reduced risk of developing hyper-
tension and other cardiovascular dis-
eases, and it has been speculated that 
the high nitrate/nitrite content of many 
vegetables may contribute to these 
cardioprotective effects. The findings 
described by Mowbray et al. (2009) 
strongly suggest an analogous role for 
nitrite/nitrate-containing nutrients in the 
protection against the injurious inflam-
matory or carcinogenic properties of 
pro-oxidative environmental stimuli 
such as UVA radiation.
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Bullous Pemphigoid:  
A Prototypical Antibody-Mediated 
Organ-Specific Autoimmune Disease
Cassian Sitaru1
Bullous pemphigoid (BP) is a prototypical organ-specific autoimmune disease. 
Autoantibodies unfold their blister-inducing potential by triggering an fcγ-
dependent inflammatory reaction. The study by Iwata et al. in this issue provides 
the first direct evidence that IgG autoantibodies from BP patients may also weaken 
cell–matrix adhesion by depleting BP180/type XVII collagen from cultured kerati-
nocytes. These novel findings shed new light on additional mechanisms of blister 
formation in pemphigoid diseases and open the way for further informative studies.
Journal of Investigative Dermatology (2009), 129, 822–824. doi:10.1038/jid.2009.12
Bullous pemphigoid (BP) is a sub-
epidermal blistering disease that 
typically affects the elderly and is 
associated with an autoimmune 
response against hemidesmosomal 
proteins (Liu and Diaz, 2001; Mihai 
and Sitaru, 2007; Olasz and Yancey, 
2008). Extensive clinical and experi-
mental evidence strongly suggests 
that autoantibodies cause the pathol-
ogy in this disease (Sitaru and Zillikens, 
2005; Leighty et al., 2007). Circulating 
autoantibodies in BP patients exhibit 
a heterogeneous specificity to several 
hemidesmosomal components, includ-
ing BP230, an intracellular constituent 
of the hemidesmosomal plaque, and 
the transmembrane protein BP180/
type XVII collagen (Sitaru and Zillikens, 
2005; Leighty et al, 2007). Mutations 
in COL17A1 in patients with general-
ized atrophic benign epidermolysis 
bullosa and in knockout mice result 
in low or absent expression of BP180/
type XVII collagen and subepidermal 
blistering (McGrath et al., 1995; Nishie 
et al., 2007). These findings suggest 
that a decrease in the expression of this 
hemidesmosomal antigen may weaken 
cell–matrix adhesion in the skin and 
eventually result in dermal–epidermal 
separation.
Autoantibodies to the transmem-
brane antigen BP180, but not to the 
intracellularly located BP230, were 
hypothesized to be pathogenically rel-
evant (Liu and Diaz, 2001; Sitaru and 
Zillikens, 2005). Indeed, experimental 
evidence generally supports the patho-
genic role of autoantibodies to BP180 
for blister formation. IgG autoantibod-
ies, affinity purified against recombi-
nant BP180 from patients with BP and 
pemphigoid gestationis, induce der-
mal–epidermal separation in cryosec-
tions of human skin when co-incubated 
with leukocytes from healthy donors 
(Sitaru and Zillikens, 2005). In 1993, 
Liu et al. first provided evidence for a 
pathogenic role of autoantibodies to 
type XVII collagen/BP180 in vivo (Liu 
et al., 1993). The authors demonstrated 
that rabbit antibodies generated against 
murine BP180 induce subepidermal 
blisters when passively transferred 
into neonatal mice. More recently, 
further animal models reproduc-
ing blister formation in BP have been 
developed using mice that express the 
human form of the BP180 antigen 
injected with BP patient autoantibod-
ies. Studies performed mainly with 
the experimental model developed by 
Liu et al. (1993) revealed that subepi-
dermal blistering triggered by rabbit 
IgG specific to murine BP180 depends 
on complement activation, mast cell 
degranulation, macrophage activation, 
and neutrophilic infiltration. Reactive 
oxygen species and proteases, such as 
gelatinase B/MMP-9 and elastase, are 
critically involved in blister formation 
in vivo and in vitro (Liu and Diaz, 2001; 
Liu, 2004; Sitaru and Zillikens, 2005; 
Leighty et al., 2007). These findings par-
tially match the pathology observed in 
BP patients and support the prevailing 
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